Startups channel feed – Endpoints News

Startups channel feed

Septerna bags $288M upsized IPO for GPCR drugs

7 months ago

Sanofi backs fibrosis biotech Agomab as it raises $89M Series D

7 months ago

Radiopharma startups stay hot as Alpha-9 bags $175M Series C

7 months ago

Life sciences investor Dimension seeks to raise $500M second fund

7 months ago

Houston startup March Biosciences raises $28M to get CAR-T into Phase 2

7 months ago

Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

7 months ago

Be Bio raises $82M to fund work on B cell therapy in hemophilia B

7 months ago

Q3 biotech roundup: The 2024 turnaround sputters into a critical Q4 finale

7 months ago

Septerna outlines $157M IPO after entering the clinic with GPCR pipeline

7 months ago

Former Karuna crew quickly assembles $225M for next neuro bet at Seaport

7 months ago

Secretive Treeline Biosciences discloses $421M financing in filing

7 months ago

RNA gene therapy startup Shape hunts for new CEO as Series C awaits

7 months ago

Hospitals gush about new AI note-taking tools. It may leave the human medical scribes who originated the roles behind

7 months ago

Life sciences investor KdT Ventures raises $100M fund to back new startups

7 months ago

Seeking to treat obesity drug side effect, Neurogastrx releases data on drug for GLP-1-associated nausea, vomiting

7 months ago

Tolerance Bio emerges from stealth with $17.2M to advance therapies developed from the thymus

7 months ago

Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock

7 months ago

VC firm targets $35M second fund to back startups led by scientists

7 months ago

Biotech startups Upstream and CAMP4 price Friday IPOs

7 months ago

Eli Lilly inks another obesity pact, doubling down on small Swiss partner

7 months ago

Suki nabs $70M Series D to arm doctors with AI tools

7 months ago

Purespring nabs $105M to take gene therapy into the clinic as IgAN field matures

7 months ago

John Maraganore's RNAi biotech City Therapeutics debuts with $135M Series A

7 months ago

Orasis snags $78M to launch presbyopia eye drops more than a year after FDA approval

7 months ago

First page Previous page 7 8 91011 12 13 Next page Last page